Akeso clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-08
What changed in the last 30 days
5 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 4 with minor changes only.
- Minor: Subcutaneous Injection of Ebronucimab in Chinese Healthy Male Subjects Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Not Yet Recruiting
- Minor: Label,Clinical Study Evaluating the Safety, Tolerability and Preliminary Efficacy of AK127 in Combination With AK104 · Advanced Malignant Tumors Trial completed
- Minor: Anti-PD-1 and LAG-3 Bispecific Antibody(AK129) Combined With Chemotherapy With or Without Cadonilimab in the First-line Treatment of Unresectable Locally Advanced or Metastatic G/ GEJ Adenocarcinoma Trial status changed: Unknown → Completed
- Notable: AK157D1 for Injection in Advanced Solid Tumors Recruitment opened
- Minor: AK129 · Advanced Malignant Tumors Trial completed
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-20 | NCT07883213 A Study to Evaluate the Efficacy and Safety of AK139 in Patients With Prurigo Nodularis. | Phase 2 | Not Yet Recruiting |
| 2026-10-15 | NCT07875426 A Trial to Evaluate the Efficacy and Safety of AK139 in Participants With Chronic… | Phase 2 | Not Yet Recruiting |
Active trials by phase
| Phase 1 | 14 | |
| Phase 1/2 | 18 | |
| Phase 2 | 26 | |
| Phase 3 | 23 |
Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials, top 10 of 23
Lung Cancer (15) · Non-Small Cell Lung Cancer (NSCLC) (13) · Colorectal Cancer (6) · Liver Cancer (6) · Pancreatic Cancer (5) · Breast Cancer (4) · Atopic Dermatitis (3) · Gastric Cancer (3) · Head & Neck Cancer (3) · Acute Myeloid Leukemia (AML) (2)
Get alerts when Akeso's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.